Kobayashi Pharmaceutical Co., Ltd. (Head Office: Osaka City, President: Kaichi Toyoda) operates under the slogan "Turning 'I wish I had this' into reality," providing products that create new markets and products with added value. For Autumn 2026, we will launch three main products: "Gyurac," a medication to improve recurrent symptoms of Irritable Bowel Syndrome (IBS); "Nodo-nu-ru Nure Mask Gokujo Kashitsu," a steam mask with the dual effect of a heat pack and humidifying filter to relieve dry throat discomfort; and "Kiribai Neru Toki Decollete Kairo," a warming pack for use during sleep that gently warms the shoulder area. We aim for first-year sales of 190 million yen. Pharmaceuticals (3 items) ● Gyurac (Quasi-drug) (Sales Name: Gyurac) Product Features: A switch OTC drug that improves recurrent symptoms of "Irritable Bowel Syndrome (IBS)" characterized by sudden diarrhea caused by stress or anxiety. Volume / Manufacturer's Suggested Retail Price (excluding tax): 10 tablets / 1,000 yen Release Date: September 30 ● [Renewal] Nodo-nu-ru Chintsu Capsule EX (Class 2 Specified-use Drug) (Sales Name: Chintsu Capsule EX) Product Features: An oral medication that quickly and effectively works from within the body for severe throat pain and fever, with dual pain-relieving ingredients and the maximum amount*1 of anti-inflammatory ingredient. Volume / Manufacturer's Suggested Retail Price (excluding tax): 18 capsules / 1,100 yen Release Date: August 26 *1 Contains the maximum amount according to the manufacturing and marketing approval standards for general antipyretic analgesics. Approval standards are the scope of pharmaceuticals established by the Ministry of Health, Labour and Welfare to improve the efficiency of approval procedures. ● Gohonarse (Class 2 Specified-use Drug) (Sales Name: Gohonarse) Product Features: Suppresses inflammation deep in the trachea, normalizes hypersensitive airways, and relieves coughs. A treatment for persistent coughs. Large capacity type. V